Triple
T15982903
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Vertex Pharmaceuticals |
E387617
|
entity |
| Predicate | collaboratesWith |
P37
|
FINISHED |
| Object |
CRISPR Therapeutics
CRISPR Therapeutics is a biotechnology company focused on developing gene-editing therapies using CRISPR/Cas9 technology to treat serious diseases.
|
E1188105
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: CRISPR Therapeutics | Statement: [Vertex Pharmaceuticals, collaboratesWith, CRISPR Therapeutics]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: CRISPR Therapeutics Context triple: [Vertex Pharmaceuticals, collaboratesWith, CRISPR Therapeutics]
-
A.
Editas Medicine
Editas Medicine is a biotechnology company focused on developing CRISPR-based gene-editing therapies to treat serious genetic diseases.
-
B.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company specializing in the development of RNA interference (RNAi)-based therapeutics for genetically defined diseases.
-
C.
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
-
D.
Flagship Pioneering
Flagship Pioneering is a venture creation firm and life sciences investment company known for founding and building innovative biotechnology companies, including Moderna.
-
E.
Horizon Discovery
Horizon Discovery is a biotechnology company specializing in gene editing and cell-based research tools used for drug discovery and development.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: CRISPR Therapeutics Triple: [Vertex Pharmaceuticals, collaboratesWith, CRISPR Therapeutics]
Generated description
CRISPR Therapeutics is a biotechnology company focused on developing gene-editing therapies using CRISPR/Cas9 technology to treat serious diseases.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: CRISPR Therapeutics Target entity description: CRISPR Therapeutics is a biotechnology company focused on developing gene-editing therapies using CRISPR/Cas9 technology to treat serious diseases.
-
A.
Editas Medicine
Editas Medicine is a biotechnology company focused on developing CRISPR-based gene-editing therapies to treat serious genetic diseases.
-
B.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company specializing in the development of RNA interference (RNAi)-based therapeutics for genetically defined diseases.
-
C.
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
-
D.
Flagship Pioneering
Flagship Pioneering is a venture creation firm and life sciences investment company known for founding and building innovative biotechnology companies, including Moderna.
-
E.
Horizon Discovery
Horizon Discovery is a biotechnology company specializing in gene editing and cell-based research tools used for drug discovery and development.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d86da94ccc819083d187f5dc6a123e |
completed | April 10, 2026, 3:25 a.m. |
| NER | Named-entity recognition | batch_69e15755b5548190acfa29eecb11e675 |
completed | April 16, 2026, 9:40 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ffc3cdf7848190848e9081027dc027 |
completed | May 9, 2026, 11:31 p.m. |
| NEDg | Description generation | batch_69ffc5669c1c81909bacf61c96cb7816 |
completed | May 9, 2026, 11:38 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69ffc5c7db1c8190b4e1de6f6e3ce8a0 |
completed | May 9, 2026, 11:39 p.m. |
Created at: April 10, 2026, 4:54 a.m.